July 25, 2014 1:16 PM ET

Biotechnology

Company Overview of Diatide, Inc.

Company Overview

As of October 22, 1999, Diatide, Inc. was acquired by Schering Berlin, Inc. Diatide, Inc. is a development stage specialty pharmaceutical company engaged in the discovery, development, and commercialization of patented, disease-specific imaging agents, and therapeutics drugs for life-threatening diseases and conditions. The company is headquartered at Londonderry, New Hampshire.

Nine Delta Drive

Londonderry, NH 03053

United States

88 Employees

Phone:

603-437-8970

Key Executives for Diatide, Inc.

Diatide, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Gemmus Pharma Inc. United States
Signalway Antibody Co.,Ltd United States
GangaGen, Inc. United States
Xoma (US) LLC United States
Biomedica Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Diatide, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.